Biohit Oyj (OHEL:BIOBV) FCF Margin % : 17.55% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biohit Oyj's Free Cash Flow for the six months ended in Dec. 2023 was €1.15 Mil. Biohit Oyj's Revenue for the six months ended in Dec. 2023 was €6.58 Mil. Therefore, Biohit Oyj's FCF Margin % for the quarter that ended in Dec. 2023 was 17.55%.

As of today, Biohit Oyj's current FCF Yield % is 2.18%.

The historical rank and industry rank for Biohit Oyj's FCF Margin % or its related term are showing as below:

OHEL:BIOBV' s FCF Margin % Range Over the Past 10 Years
Min: -87.92 Med: -3.1 Max: 16.34
Current: 5

During the past 13 years, the highest FCF Margin % of Biohit Oyj was 16.34%. The lowest was -87.92%. And the median was -3.10%.

OHEL:BIOBV's FCF Margin % is ranked better than
83.29% of 1041 companies
in the Biotechnology industry
Industry Median: -145.04 vs OHEL:BIOBV: 5.00

Biohit Oyj FCF Margin % Historical Data

The historical data trend for Biohit Oyj's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj FCF Margin % Chart

Biohit Oyj Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

0.37

-0.56

-5.10

16.34

5.00

Biohit Oyj Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-0.82	16.39	17.48	-7.69	17.55

Competitive Comparison of Biohit Oyj's FCF Margin %

For the Biotechnology subindustry, Biohit Oyj's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biohit Oyj's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's FCF Margin % falls into.

Biohit Oyj FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biohit Oyj's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.654	/	13.076
	=	5.00 %

Biohit Oyj's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1.154	/	6.576
	=	17.55 %

Biohit Oyj FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biohit Oyj (OHEL:BIOBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Laippatie 1, Helsinki, FIN, 00880

Website

https://www.biohithealthcare.com

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines